logo
Plus   Neg
Share
Email

Bayer, Daré Bioscience Sign License Agreement On Ovaprene

Bayer and Daré Bioscience Inc. (DARE) entered into exclusive license agreement for U.S. commercial rights to investigational hormone-free, monthly contraceptive Ovaprene.

In Monday regular trade, DARE is trading at $2.00, up $1.16 or 139.52 percent.

Bayer may commercialize Daré's investigational contraceptive product, Ovaprene in the United States once approved by the FDA.

The licensing option becomes effective with a payment of $20 million from Bayer to Daré.

Daré might be eligible to receive commercial milestone payments potentially totaling $310 million as well as double-digit tiered royalties on net sales.

As per the deal, Daré will receive an upfront payment and access to Bayer's clinical and market capabilities while retaining control over Ovaprene's development and regulatory approval process.

Daré plans to file an Investigational Device Exemption for Ovaprene in the first half of 2020 and to initiate a pivotal contraceptive effectiveness and safety clinical study of Ovaprene in the second half of 2020.

If successful, Daré expects that study to support marketing approvals of Ovaprene in the U.S., Europe and other countries worldwide.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. FedEx is asking NFL team Washington Redskins to change its name for its racist connotations. The delivery services company, which is a major sponsor for the team, made the suggestion following increasing pressure from its investors amid the ongoing protests against racial injustice and inequality that arose from the killing of African-American George Floyd.
Follow RTT